AU2001259242A1 - Process for the preparation of chemical compounds - Google Patents

Process for the preparation of chemical compounds

Info

Publication number
AU2001259242A1
AU2001259242A1 AU2001259242A AU5924201A AU2001259242A1 AU 2001259242 A1 AU2001259242 A1 AU 2001259242A1 AU 2001259242 A AU2001259242 A AU 2001259242A AU 5924201 A AU5924201 A AU 5924201A AU 2001259242 A1 AU2001259242 A1 AU 2001259242A1
Authority
AU
Australia
Prior art keywords
6alkyl
6alkoxy
substituted
fluorine atoms
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001259242A
Other languages
English (en)
Inventor
John F. Eaddy
Russ N. Fitzgerald
David Kendall Jung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001259242A1 publication Critical patent/AU2001259242A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AU2001259242A 2000-04-28 2001-04-27 Process for the preparation of chemical compounds Abandoned AU2001259242A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20040000P 2000-04-28 2000-04-28
US60200400 2000-04-28
PCT/US2001/013801 WO2001083479A2 (en) 2000-04-28 2001-04-27 Process for the preparation of pyrazolopyridine derivatives

Publications (1)

Publication Number Publication Date
AU2001259242A1 true AU2001259242A1 (en) 2001-11-12

Family

ID=22741567

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001259242A Abandoned AU2001259242A1 (en) 2000-04-28 2001-04-27 Process for the preparation of chemical compounds

Country Status (7)

Country Link
EP (1) EP1276742B1 (de)
JP (1) JP2003531906A (de)
AT (1) ATE268771T1 (de)
AU (1) AU2001259242A1 (de)
DE (1) DE60103752T2 (de)
ES (1) ES2222372T3 (de)
WO (1) WO2001083479A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1546128B1 (de) 2002-08-19 2006-05-03 Glaxo Group Limited Pyrimidinderivate als selektive cox-2-inhibitoren
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
UA103319C2 (en) 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds
FR2950345B1 (fr) * 2009-09-18 2011-09-23 Sanofi Aventis Derives acetyleniques de 5-phenyl-pyrazolopyridine, leur preparation et leur application en therapeutique
LT2925757T (lt) 2012-11-19 2017-12-27 Novartis Ag Junginiai ir kompozicijos, skirti parazitinių ligų gydymui
US8871754B2 (en) 2012-11-19 2014-10-28 Irm Llc Compounds and compositions for the treatment of parasitic diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4821117B1 (de) * 1970-09-25 1973-06-26
JPS5753486A (en) * 1980-09-17 1982-03-30 Mitsubishi Paper Mills Ltd Preparation of 3-formyl-pyrazolo 1,5-a pyridine derivative
JPS57126489A (en) * 1981-01-28 1982-08-06 Mitsubishi Paper Mills Ltd Preparation of pyrazolo(1, 5-a)pyridine derivative
JPS60248689A (ja) * 1984-05-24 1985-12-09 Mitsubishi Paper Mills Ltd 3−(3′−ピラゾロ〔1,5−a〕ピリジル)アクロレイン誘導体

Also Published As

Publication number Publication date
WO2001083479A3 (en) 2002-05-23
DE60103752D1 (de) 2004-07-15
DE60103752T2 (de) 2005-07-14
WO2001083479A2 (en) 2001-11-08
ES2222372T3 (es) 2005-02-01
EP1276742B1 (de) 2004-06-09
EP1276742A2 (de) 2003-01-22
ATE268771T1 (de) 2004-06-15
JP2003531906A (ja) 2003-10-28

Similar Documents

Publication Publication Date Title
EP1103552A4 (de) Benzothiepin-derivate, verfahren zu ihrer herstellung und ihre verwendungen
DE60236851D1 (en) Pyrimidinmatrixmetalloproteinaseinhibitoren
AU2002211216A1 (en) Substituted aminopropoxyaryl derivatives useful as agonists for lxr
IS2598B (is) Þíenópýrimidíndíón og notkun þeirra í mótun sjálfnæmissjúkdóma
GB0117583D0 (en) Novel compounds
CA2449874A1 (en) New indole derivatives with 5-ht6 receptor affinity
IL97049A0 (en) Aryl-and heteroarylethenylene derivatives,their preparation and pharmaceutical compositions containing them
CA2401711A1 (en) Cyclic amide derivatives
WO2003027050A3 (en) Process for preparing pentacene derivatives
EP0882714A4 (de) Substituierte vinylpyridinderivate und arzneimittel, die diese enthalten
NZ332923A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
FI101227B1 (fi) Menetelmä farmaseuttisesti aktiivisten 4-desoksi-4-epipodofyllotoksiinijohdannaisten valmistamiseksi
AU2001259242A1 (en) Process for the preparation of chemical compounds
GB9930358D0 (en) Process for the preparation of chemical compounds
EP0713877A4 (de) Qinghaosuderivate zur bekämpfung von aids
RU94033098A (ru) Способ производных 1-замещенного-5/4h/-тетразолинона
ATE204278T1 (de) Serotoninergische ergolin derivate
WO2000064902A3 (en) Process for the preparation of calanolide precursors
SI1572198T1 (sl) Nove farmacevtske spojine z alfa2 receptorsko aktivnostjo
EA200200379A3 (ru) Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции
EP1241167A4 (de) 3-ethyl, 3-propyl- oder 3-butyl-chroman und -thiochromanderivate
NO953557D0 (no) Antitumorpreparater og fremgangsmåte for deres fremstilling
ES528451A0 (es) Procedimiento de preparacion de un derivado 1,1-difenilpropan-1-ol
GB0114699D0 (en) Organic compounds
WO2001081315A3 (en) Amino-imidazole derivatives for treating cancer